TAP Block , Intrathecal Morphine Or Their Combination For Post Operative Analgesia Following TAH
Launched by MINIA UNIVERSITY · Mar 12, 2025
Trial Information
Current as of April 29, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of three different methods for managing pain after a total abdominal hysterectomy, which is a surgery to remove the uterus. The researchers are comparing a specific type of pain relief called a TAP block, a medication called intrathecal morphine, and a combination of both. They want to see how well these methods help with pain by looking at how long it takes for patients to ask for pain medicine, their pain levels, how much pain medicine they use, when they can start moving around after surgery, and if there are any complications.
To be eligible for this trial, participants must be women between the ages of 30 and 70 who are scheduled to have this surgery and are in generally good health. They should also be willing to provide informed consent, which means they understand the study and agree to participate. However, those who have allergies to the medications being studied, certain health issues, or infections at the injection site cannot participate. If you join this trial, you can expect close monitoring for your pain management and overall recovery following your surgery.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients aged 30 to 70 years.
- • Elective total abdominal hysterectomy.
- • ASA physical status I or II.
- • Willingness to provide informed consent.
- Exclusion Criteria:
- • Refusal of the block.
- • Allergy to study medications.
- • Preexisting coagulation disorders.
- • Local infection at the site of needle insertion.
- • Uncontrolled respiratory or cardiac disorders.
- • Impaired kidney or liver function.
About Minia University
Minia University is a prestigious educational institution located in Egypt, dedicated to advancing medical research and clinical trials. With a commitment to fostering innovation and improving healthcare outcomes, the university collaborates with a diverse range of stakeholders, including healthcare professionals and researchers. Minia University aims to enhance clinical practices through rigorous research methodologies and ethical standards, contributing to the body of knowledge in the medical field while addressing local and global health challenges. The university's clinical trial initiatives are designed to evaluate new treatments and interventions, ensuring a positive impact on patient care and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minya, El Minya, Egypt
Patients applied
Trial Officials
sohair Adeeb, assist.prof.
Principal Investigator
Minia University, faculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported